COMMUNIQUÉS West-GlobeNewswire

Kura Oncology Announces Commencement of Public Offering of Common Stock
18/06/2019
SAN DIEGO, June 18, 2019 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that it has [...]
Alder BioPharmaceuticals® to Present at BMO Capital Markets 2019 Prescription for Success Healthcare Conference
18/06/2019
BOTHELL, Wash., June 18, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Idera Pharmaceuticals to Present at the 2019 JMP Securities Life Sciences Conference
18/06/2019
EXTON, Pa., June 18, 2019 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today announced that the company will present at the 2019 JMP Securities Life Sciences Conference on Thursday, June 20, 2019 at 1: [...]
Corizon Health Chosen to Continue Services at the Passaic County Jail
18/06/2019
BRENTWOOD, Tenn., June 18, 2019 (GLOBE NEWSWIRE) -- Corizon Health recently won a competitive bidding process to continue providing medical and mental health services to offenders in the Passaic County Jail. The health [...]
Delta 9 Announces Minimum $10 Million Public Offering of 8.5% Convertible Debenture Units
18/06/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. WINNIPEG, Manitoba, June 18, 2019 (GLOBE NEWSWIRE) -- Delta 9 Cannabis Inc. (“ Delta 9 ” or the “ Company ”) (TSXV: NINE [...]
Aleafia Health Announces Election of Directors
18/06/2019
TORONTO, June 18, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (the “ Company ”) (TSX: ALEF) (OTC: ALEAF) (FRA:ARAH) is pleased to announce the results of the vote on the election of directors at its annual and special [...]
Blake Insomnia Therapeutics, Inc Completes Name Change to BioHemp International, Inc (OTC: BKIT) and Appoints Daniel Blum as New CEO to Spearhead CBD Distribution Consolidation Focus
18/06/2019
NEW YORK, June 18, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – The Company, previously Blake Insomnia Therapeutics Inc, confirms its successful name change to BioHemp International, Inc. (OTC: BKIT) and announces the [...]
CROSSJECT : Accord commercial avec DESITIN Pharma sur ZENEO® Midazolam en Allemagne
18/06/2019
Communiqué de presse Accord commercial avec DESITIN Pharma sur ZENEO® Midazolam en Allemagne DESITIN, acteur majeur dans le domaine de l’épilepsie en Allemagne Licence exclusive, accord de distribution et de promotion 2 [...]
Teligent, Inc. to Present at the Raymond James Life Sciences and MedTech Conference on June 19th 2019
18/06/2019
BUENA, N.J., June 18, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Raymond James Life Sciences and MedTech Conference [...]
North Bud Farms Signs Binding Letter of Intent to Acquire California Licensed Extraction Company Tanforan Ventures
18/06/2019
TORONTO, June 18, 2019 (GLOBE NEWSWIRE) -- North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) ("NORTHBUD" or the "Company") is pleased to announce that effective June 15, 2019 it has entered into a binding letter of intent [...]
Pathway Health Announces Distribution Agreement with Briggs Healthcare
18/06/2019
LAKE ELMO, Minn., June 18, 2019 (GLOBE NEWSWIRE) -- Pathway Health , a leading post-acute consulting services, strategic technology implementation, and education services firm, has signed a distribution agreement with [...]
Harrow Health, Inc to Locate Headquarters in Nashville, Tennessee
18/06/2019
NASHVILLE, Tenn., June 18, 2019 (GLOBE NEWSWIRE) -- Tennessee Governor, Bill Lee, Department of Economic and Community Development Commissioner Bob Rolfe and Harrow Health, Inc (NASDAQ: HROW) announced today that the [...]
Rinovum Women’s Health Debuts All-New Over-the-Counter Product Designed to Treat Stress Urinary Incontinence and Boost Women’s Confidence
18/06/2019
Makers of successful Stork® products for at-home conception take on light bladder leaks, a condition impacting more than 15 million women in the United States PITTSBURGH, June 18, 2019 (GLOBE NEWSWIRE) -- Rinovum Women’ [...]
Progenics Pharmaceuticals Announces Agreement with FUJIFILM Toyama Chemical Co. for Automated Bone Scan Index (aBSI) Product in Japan
18/06/2019
aBSI Leverages Artificial Intelligence to Automatically and Reliably Analyze Bone Scan Images from Prostate Cancer Patients NEW YORK, June 18, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an [...]
PROJECT HOPE ANNOUNCES TRANSITIONS IN EXECUTIVE LEADERSHIP
18/06/2019
Global health and humanitarian relief organization positions for continued growth and innovation Millwood, Virginia, June 18, 2019 (GLOBE NEWSWIRE) -- The board of directors of Project HOPE has named Rabih Torbay [...]
ContraVir Pharmaceuticals, Inc. Announces Pricing of $15.6 Million Public Offering
18/06/2019
EDISON, N.J., June 18, 2019 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (“ContraVir,” the “Company,” “we,” “our” or “us”) (NASDAQ:CTRV), a biopharmaceutical company focused on the development of therapeutic [...]
Wildflower Featured in CannabisNewsWire Publication Highlighting Legal Cannabis as a Global Profit Phenomenon
18/06/2019
NEW YORK, June 18, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsWire -- Wildflower Brands Inc. (OTCQB:WLDFF) (CSE:SUN) today announces its placement in an editorial published by CannabisNewsWire ("CNW"), a multifaceted [...]
Anchiano Therapeutics Delists Ordinary Shares from the Tel Aviv Stock Exchange
18/06/2019
CAMBRIDGE, Mass., June 18, 2019 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq: ANCN) (“Anchiano”), a pivotal-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat [...]
Menlo Therapeutics Announces Addition of Ronald A. Krasnow as General Counsel and Chief Compliance Officer
18/06/2019
REDWOOD CITY, Calif., June 18, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), [...]

Pages